Delivery Order SPE2DR25D2205-SPE2DR26F1F48
- Not listed
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $4,944.66 by the Defense Logistics Agency (DLA) for the supply of Trulicity 1.5 mg/0.5 mL pens. The contract was awarded on September 11, 2025, with an ultimate completion date of September 12, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This is a firm fixed-price delivery order awarded without any set-aside designation, reflecting a competitively awarded...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 13, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens with a ceiling value of $7,657.65. This non-competitive, firm fixed-price delivery order is expected to be completed by June 16, 2025, and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $5,500.88 by the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. This firm fixed-price delivery order is a non-set-aside contract with an ultimate completion date of July 25, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency for the supply of Trulicity 1.5 mg/0.5 ml pens valued at $3,176.08. This is a firm fixed-price delivery order with an ultimate completion date of September 25, 2025, awarded on September 24, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,788.24 for Trulicity 1.5 mg/0.5 ml pens on October 17, 2025, with completion targeted for October 20, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract specifies performance at AmerisourceBergen's Conshohocken,...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency on June 2, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens valued at $1,517.29. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of June 3, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the open competition in which AmerisourceBergen Drug Corp, a major...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 23, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens with a ceiling value of $1,858.72. This competitive award, issued without a set-aside designation, carries a firm fixed price structure with an ultimate completion date of July 24, 2025. The product will be performed and distributed from the contractor's location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a $12,765.60 delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens in 0.5 mL units. This is a firm fixed price contract with an ultimate completion date of October 28, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the contractor's capability to compete in open federal...
- The Defense Logistics Agency awarded a $10,450.62 delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL units). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by October 31, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction within the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,880.84 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens on November 3, 2025, with an ultimate completion date of November 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a single transaction under AmerisourceBergen's larger...
- SPE2DR25D2205Indefinite Delivery Contract
- SPE2DR25D2205-SPE2DR26F1F48Delivery Order
AmerisourceBergen Drug Corp was awarded a $11,761.50 firm fixed price delivery order by the Defense Logistics Agency (DLA) on November 4, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens. The contract, which is non-set-aside and competitively awarded, has an ultimate completion date of November 5, 2025, with performance to be conducted at the company's corporate office in Conshohocken, Pennsylvania. This delivery order represents a single transactional award under AmerisourceBergen's broader federal contract portfolio supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. The prime contract serves as a flexible vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and vaccines. The award demonstrates the company's continued capability to fulfill federal medical supply requirements through open competition and its critical role in supporting the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.8k | 11/4/25 |